Vice President, Global Immunology Development @ AbbVie
Therapeutic Area Head Immunoscience and Fibrosis, Clinical Development, R&D @ Bristol-Myers Squibb
Senior Director, Head Translational Immunology, BioTherapeutics Research and Development @ Pfizer
Education:
MD, Medicine @
Pomeranian Medical University
About:
Executive Director, Therapeutic Area Head, Immunoscience Discovery Medicine & Clinical Biomarkers @ Accountable for the clinical development of Immunoscience portfolio at BMS.
Responsible for:
-design and implementation of early clinical studies for Immunoscience assets,
-integration of translational medicine activities into development,
-appropriate alignment across the value chain for the effective integrated development of molecules,
-business development assessments,
Executive Director, Therapeutic Area Head, Immunoscience Discovery Medicine & Clinical Biomarkers @ Accountable for the clinical development of Immunoscience portfolio at BMS.
Responsible for:
-design and implementation of early clinical studies for Immunoscience assets,
-integration of translational medicine activities into development,
-appropriate alignment across the value chain for the effective integrated development of molecules,
-business development assessments,
-identification of novel targets, including assessment of the medical need and clinical relevance of targets in the context of disease. From April 2015 to Present (9 months) Group Medical Director Immunoscience, Exploratory Clinical and Translational Research, R&D @ Responsible for clinical development of Immunoscience projects, executing translational and clinical strategies for therapeutics targeting autoimmune and inflammatory diseases such as SLE, RA, IBD and ITP. From January 2012 to April 2015 (3 years 4 months) Senior Director, Head Translational Immunology, BioTherapeutics Research and Development @ Accountable for formulating and delivering strategic vision and mission for the Translational Immunology organization, focused on execution of the POC clinical trials through implementation of Precision Medicine strategies. From February 2011 to January 2012 (1 year) Associate Medical Director, Rheumatology, Inflammation and Autoimmunity. Clinical Development @ Clinical Director and Program Lead for Phase 0 through Phase 2 clinical studies, including pivotal trials for Systemic Lupus Erythematosus. From June 2009 to February 2011 (1 year 9 months) Immunobiology and Autoimmunity. Translational Medicine @ Director for programs focused on development of biological therapeutics for the treatment of autoimmune diseases (SLE, RA). From 2006 to 2009 (3 years) Instructor in Pediatrics @ From 2000 to 2006 (6 years) Post Doctoral Researcher @ From 1995 to 2000 (5 years)
Postdoctoral Researcher in Pathology, Hematology, Virology @ University of Pennsylvania School of Medicine From 1995 to 1999 MD, Medicine, Summa Cum Laude @ Pomeranian Medical University From 1988 to 1994 PhD, Immunology, Hematology, Summa Cum Laude @ Pomeranian Medical University From 1988 to 1994 Marek PhD is skilled in: Clinical Trials, Drug Development, Translational Medicine, Translational Research, Translational Science, Biotherapeutics, Biotechnology, Clinical Research, Inflammation, Rheumatology, Autoimmunity, Autoimmune Diseases, Medical Research, Clinical Development, Clinical Study Design
Looking for a different
Marek PhD?
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension